Financials in USD. Standardized financial statements.
A compact view of how Diaceutics PLC turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $38.43M | $32.16M | $23.70M | $19.50M | $13.94M | $12.70M | $13.44M | $10.37M | $7.37M | $4.59M |
| Revenue Growth? | +19.5% | +35.7% | +21.5% | +39.9% | +9.8% | -5.6% | +29.6% | +40.7% | +60.6% | 0.0% |
| Cost of Revenue? | $12.77M | $3.89M | $3.99M | $5.47M | $3.38M | $3.36M | $3.13M | $3.57M | $2.48M | $1.93M |
| Gross Profit? | $25.66M | $28.27M | $19.71M | $14.04M | $10.57M | $9.33M | $10.31M | $6.80M | $4.89M | $2.66M |
| Gross Margin? | +66.8% | +87.9% | +83.2% | +72.0% | +75.8% | +73.5% | +76.7% | +65.6% | +66.3% | +57.9% |
| Operating Expenses? | $25.87M | $30.73M | $22.72M | $13.71M | $10.25M | $9.94M | $8.19M | $5.59M | $3.99M | $1.77M |
| Operating Income? | -$211,965 | -$2.46M | -$3.02M | $331,000 | $313,000 | -$610,000 | $2.12M | $1.21M | $901,246 | $882,286 |
| EBITDA? | $5.60M | $2.77M | $2.40M | $3.61M | $2.11M | $178,000 | $847,581 | $1.30M | $922,178 | $584,172 |
| Income Before Tax | $301,950 | -$1.91M | -$2.44M | $478,000 | $293,000 | -$929,000 | $340,324 | $877,264 | $784,857 | $784,975 |
| Income Tax Expense | $204,966 | -$205,000 | -$692,000 | -$246,000 | -$268,000 | -$1.19M | -$57,557 | $244,957 | $121,664 | $37,836 |
| Net Income? | $96,983 | -$1.70M | -$1.75M | $724,000 | $561,000 | $263,000 | $398,000 | $632,307 | $663,193 | $747,139 |
| EPS? | $0.00 | $-0.02 | $-0.02 | $0.01 | $0.01 | $0.00 | $0.01 | $0.01 | $0.01 | $0.01 |
| Diluted EPS? | $0.00 | $-0.02 | $-0.02 | $0.01 | $0.01 | $0.00 | $0.01 | $0.01 | $0.01 | $0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality